Helena Brillembourg

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer(Current)

Universitat de Barcelona

Hospital Clínic de Barcelona

Centro de Investigación Biomédica en Red de Cáncer

Helena Brillembourg is an author at Consorci Institut D'Investigacions Biomediques August Pi I Sunyer specializing in immunology, oncology, and medicine.

Publications per year

2022–2024

Publications

The academic point‐of‐care <scp>anti‐CD19</scp> chimeric antigen receptor T‐cell product varnimcabtagene autoleucel (<scp>ARI</scp>‐0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B‐cell <scp>non‐Hodgkin</scp> lymphoma

Núria Martínez‐Cibrián, Valentín Ortiz‐Maldonado, Marta Español‐Rego et al. · British Journal of Haematology · 2023 · 21 citations · Full text

Medicine, Immunology, Oncology +17

The role of chimeric antigen receptor T cells targeting more than one antigen in the treatment of B‐cell malignancies

Helena Brillembourg, Núria Martínez‐Cibrián, Mireia Bachiller et al. · British Journal of Haematology · 2024 · 17 citations · Full text

Medicine, Immunology, Oncology +13

Efficacy of early transfusion of convalescent plasma with high‐titer <scp>SARS‐CoV</scp>‐2 neutralizing antibodies in hospitalized patients with <scp>COVID</scp>‐19

Cristina Sanz, Meritxell Nomdedéu, Arturo Pereira et al. · Transfusion · 2022 · 13 citations · Full text

Medicine, Immunology, Infectious Diseases +14

1–3 of 3